BioSpace News Archive

Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today the activation of two new clinical sites for the currently enrolling ELPIS II Trial, evaluating Lomecel-B injection into the myocardium of infants with Hypoplastic Left Heart Syndrome (HLHS), a rare and life-threatening congenital heart defect.

Oncotelic Therapeutics, Inc., a leading developer of TGF-β therapeutics for oncology and virology announced an update on the Phase 2 C001 Covid Study and the OT-101-ONC program for the potential first-in-class investigational TGF-β immunotherapy, OT-101, in difficult-to-treat cancers.

Opus Genetics today announced two key appointments to its founding executive team. Ash Jayagopal, Ph.D., has joined the company as Chief Scientific Officer (CSO) and Joe Schachle has joined as Chief Operating Officer (COO).

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO for the treatment of solid tumors, announced positive interim data from the ongoing LungFit® GO pilot study in Australia.

Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, will present at the Benzinga Global Small Cap Conference being held virtually October 27-28, 2021.

Theravance Biopharma, Inc. (NASDAQ: TBPH), will report its third quarter 2021 financial results and provide a business update after market close on Wednesday, November 3, 2021

IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), today announced that it has entered into an initial distribution agreement with Mobile SCANMED Systems SP. z o.o. (“Mobile SCANMED Systems”) to exclusively sell the Company’s ProSense™ Cryoablation System and disposables in Poland.

Both Scientific Solutions Inc. and Management Solutions will be attending the 10th Annual MJBizCon in Las Vegas this week.

INVO Bioscience, Inc. today announced that four poster abstracts were presented discussing INVOcell at the 77th Scientific Congress & Expo of the American Society for Reproductive Medicine (ASRM) being held this week in Baltimore, Maryland.

RaySearch Laboratories AB announces that La Clinique Générale-Beaulieu, a part of Swiss Medical Network in Switzerland, is the first center in the world to treat a patient using the Accuray Radixact® radiation treatment delivery system with RaySearch treatment planning system RayStation®* and oncology information system RayCare®*.